Supported in part by NIH/NIDDK R21 DK077064 and International Organization for Study of Inflammatory Bowel Disease (IOIBD).
Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: A systematic review and meta-analysis†
Article first published online: 31 JAN 2012
Copyright © 2012 Crohn's & Colitis Foundation of America, Inc.
Inflammatory Bowel Diseases
Volume 18, Issue 10, pages 1872–1884, October 2012
How to Cite
Kaul, A., Hutfless, S., Liu, L., Bayless, T. M., Marohn, M. R. and Li, X. (2012), Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: A systematic review and meta-analysis. Inflamm Bowel Dis, 18: 1872–1884. doi: 10.1002/ibd.22862
- Issue published online: 13 SEP 2012
- Article first published online: 31 JAN 2012
- Manuscript Accepted: 26 NOV 2011
- Manuscript Received: 9 NOV 2011
Additional Supporting Information may be found in the online version of this article.
|IBD_22862_sm_SuppTab1.doc||52K||Supporting Information Table 1. Results from 14 studies with overlapping study populations included.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.